Paper Details

  1. Home
  2. Paper Details

Association of musculoskeletal complaints and gliptin use: review of spontaneous reports.

Author: CerezaGloria, FiguerasAlbert, TarapuésMónica

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study investigates spontaneous reports related to musculoskeletal (MSk) adverse effects associated with the use of gliptins, a class of antidiabetic drugs. The aim is to characterize and analyze the reported adverse effects.
Paper Details　
Original Abstract of the Article :
Gliptins are new oral antidiabetic drugs that increase insulin levels through dipeptidyl peptidase-4 inhibition. Recently, the association of serious musculoskeletal (MSk) adverse effects with the gliptin use has been suggested. The aim is to describe and analyze the characteristics of spontaneous r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/pds.3503

データ提供：米国国立医学図書館（NLM）

Gliptins and Musculoskeletal Complaints: A Potential Link to Explore

This research explores the potential association between gliptins, a class of antidiabetic drugs, and musculoskeletal (MSK) complaints. This study is like a group of scientists examining a potential link between a widely used medication and a troubling side effect. The authors review spontaneous reports of MSK adverse effects associated with gliptin use, seeking to understand the nature and characteristics of these reports.

Gliptins and MSK Complaints: A Potential Area of Concern

The study's findings reveal a potential association between gliptin use and MSK adverse effects, prompting further investigation into this potential link. This discovery is like uncovering a hidden warning sign in the desert of drug safety, a reminder that even seemingly safe medications can have unexpected side effects. The research encourages further research to clarify the relationship between gliptins and MSK complaints, ensuring that patients are well-informed about potential risks.

Navigating the Desert of Drug Safety: A Call for Transparency

This research underscores the importance of ongoing monitoring and research to ensure the safety of medications. The study's findings highlight the need for transparency and open communication between healthcare providers and patients about potential side effects associated with medication use. This research serves as a reminder that the pursuit of safe and effective treatments requires continuous vigilance and a proactive approach to identifying and addressing potential risks.

Dr.Camel's Conclusion

This research highlights a potential association between gliptin use and musculoskeletal complaints, prompting further investigation into this potential link. The study underscores the importance of ongoing monitoring and research to ensure the safety of medications and the need for transparency and open communication between healthcare providers and patients about potential side effects.

Date :
  1. Date Completed 2014-05-02
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

23960039

DOI: Digital Object Identifier

10.1002/pds.3503

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.